找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Cardiac Markers; Alan H. B. Wu Book 2003Latest edition Springer Science+Business Media New York 2003 Laboratory.Laboratory Medicine.Lipopr

[復(fù)制鏈接]
樓主: 滲漏
41#
發(fā)表于 2025-3-28 16:53:49 | 只看該作者
42#
發(fā)表于 2025-3-28 19:01:34 | 只看該作者
43#
發(fā)表于 2025-3-29 02:04:37 | 只看該作者
44#
發(fā)表于 2025-3-29 06:18:51 | 只看該作者
Nonuniformly Expanding Attractors,ns in patients with acute coronary syndromes (ACS) ., and a role in guiding antithrombotic therapy ., it is crucial that troponin assays have robust analytical performance to allow for reliable measurements, especially at low abnormal ranges.
45#
發(fā)表于 2025-3-29 09:23:57 | 只看該作者
46#
發(fā)表于 2025-3-29 15:03:01 | 只看該作者
Interferences in Immunoassays for Cardiac Troponinns in patients with acute coronary syndromes (ACS) ., and a role in guiding antithrombotic therapy ., it is crucial that troponin assays have robust analytical performance to allow for reliable measurements, especially at low abnormal ranges.
47#
發(fā)表于 2025-3-29 16:04:50 | 只看該作者
Nontraditional Security Concerns in Indiaed heart failure in children treated with the anthracycline daunorubicin, there has been an increased awareness of the potential for cardiovascular side effects during the course of cancer chemotherapy.
48#
發(fā)表于 2025-3-29 21:06:11 | 只看該作者
Nonunions: Treatment Objectives and Optionsspartate aminotransferase, CK and CK-MB, has gradually been replaced—although at different speeds in various countries—by automated quantitative immunoassays for mass determination of myoglobin, CK-MB, cardiac troponin I (cTnI), and cardiac troponin T (cTnT) ..
49#
發(fā)表于 2025-3-30 02:59:50 | 只看該作者
The Use of Cardiac Biomarkers to Detect Myocardial Damage Induced by Chemotherapeutic Agentsed heart failure in children treated with the anthracycline daunorubicin, there has been an increased awareness of the potential for cardiovascular side effects during the course of cancer chemotherapy.
50#
發(fā)表于 2025-3-30 04:04:53 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 16:50
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
若尔盖县| 普格县| 苏尼特右旗| 龙州县| 健康| 普兰县| 塔城市| 盐亭县| 洪泽县| 宝鸡市| 土默特右旗| 永济市| 许昌县| 晋城| 墨竹工卡县| 榆树市| 伊宁市| 泰安市| 水富县| 阳泉市| 乌鲁木齐市| 武宣县| 库车县| 视频| 银川市| 咸阳市| 乌鲁木齐市| 思茅市| 定陶县| 迁安市| 五大连池市| 什邡市| 巩义市| 鲜城| 凤庆县| 青阳县| 浙江省| 普陀区| 大埔区| 高青县| 淮北市|